title: [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
authors.affiliation: Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie, Stuttgart.
authors.forename: M
authors.initials: M
authors.lastname: Schwab
authors.forename: K
authors.initials: K
authors.lastname: Herrlinger
authors.forename: E
authors.initials: E
authors.lastname: Schaeffeler
authors.forename: E F
authors.initials: EF
authors.lastname: Stange
mesh_terms: D001379:Azathioprine / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced; D015122:Mercaptopurine / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D008780:Methyltransferases / Q000097:blood / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D013866:Thioguanine / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D013866:Thioguanine; D001379:Azathioprine